<?xml version="1.0" encoding="utf-8"?>
<graph alreadyRendered="yes">
<graphPosition x="422.5" y="351.9" />
<graphZoom x="1" y="1" />
<relationFilters>
<relation id="">AUGMENTS</relation>
<relation id="">STIMULATES</relation>
<relation id="">COEXISTS_WITH</relation>
<relation id="">DISRUPTS</relation>
<relation id="">LOCATION_OF</relation>
<relation id="">PROCESS_OF</relation>
<relation id="">INHIBITS</relation>
<relation id="">INTERACTS_WITH</relation>
<relation id="">ASSOCIATED_WITH</relation>
<relation id="">AFFECTS</relation>
<relation id="">TREATS</relation>
<relation id="">ISA</relation>
<relation id="">CAUSES</relation>
</relationFilters>
<node id="C0016030" name="Fibroblasts" semtype="cell" visible="true" color="#CBFFA7" x="152" y = "-170" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0016030"/>
<node id="C0206588" name="Receptors, Nuclear" semtype="aapp" visible="true" color="#FFFFC6" x="324" y = "83" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0206588"/>
<node id="C0303814" name="Diglycidyl ether" semtype="orch" visible="true" color="#FFFFC6" x="41" y = "-10" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0303814"/>
<node id="C0220894" name="phthalate" semtype="orch" visible="true" color="#FFFFC6" x="336" y = "37" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0220894"/>
<node id="C0021655" name="Insulin Resistance" semtype="patf" visible="true" color="#EEC8DE" x="349" y = "-127" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0021655" omim_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=125853"/>
<node id="C0021760" name="Interleukin-6" semtype="aapp" visible="true" color="#FFFFC6" x="138" y = "13" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0021760"/>
<node id="C0030305" name="Pancreatitis" semtype="dsyn" visible="true" color="#EEC8DE" x="406" y = "-209" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0030305" omim_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&amp;cmd=Retrieve&amp;list_uids=608189,167800"/>
<node id="C0038889" name="Endogenous Surfactants" semtype="bacs" visible="true" color="#FFFFC6" x="11" y = "-161" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0038889"/>
<node id="C1336636" name="TLR4 gene" semtype="gngm" visible="true" color="#D2A2A2" x="86" y = "169" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C1336636" entrezgene_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=7099"/>
<node id="C0225700" name="Pneumocyte, type 2" semtype="cell" visible="true" color="#CBFFA7" x="19" y = "-20" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0225700"/>
<node id="C0289313" name="rosiglitazone" semtype="orch" visible="true" color="#FFFFC6" x="-13" y = "179" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0289313"/>
<node id="C0034721" name="Rattus" semtype="mamm" visible="true" color="#C6EFF7" x="260" y = "235" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0034721"/>
<node id="C0166417" name="PPAR gamma" semtype="aapp" visible="true" color="#FFFFC6" x="236" y = "37" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0166417" entrezgene_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=5465"/>
<node id="C0166415" name="PPAR alpha" semtype="aapp" visible="true" color="#FFFFC6" x="41" y = "84" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0166415" entrezgene_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=5465"/>
<node id="146" name="ADRA1D" semtype="gngm" visible="true" color="#D2A2A2" x="138" y = "61" entrezgene_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=146"/>
<node id="C0122111" name="HMGA2 Protein" semtype="aapp" visible="true" color="#FFFFC6" x="64" y = "267" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0122111" entrezgene_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=8091"/>
<node id="C1512753" name="Inflammation Process" semtype="ortf" visible="true" color="#DCD1EB" x="292" y = "119" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C1512753"/>
<node id="C0680323" name="Western society" semtype="popg" visible="true" color="#C6EFF7" x="260" y = "-161" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0680323"/>
<node id="C0028754" name="Obesity" semtype="dsyn" visible="true" color="#EEC8DE" x="248" y = "-62" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0028754" omim_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&amp;cmd=Retrieve&amp;list_uids=300306,601665"/>
<node id="C0043552" name="Zymosan" semtype="bacs" visible="true" color="#FFFFC6" x="200" y = "130" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0043552"/>
<node id="C0796494" name="Lobe" semtype="bpoc" visible="true" color="#CBFFA7" x="172" y = "220" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0796494"/>
<node id="C0543567" name="Diabetes mellitus, overt" semtype="dsyn" visible="true" color="#EEC8DE" x="165" y = "-149" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0543567"/>
<node id="C0006434" name="Burn injury" semtype="inpo" visible="true" color="#EEC8DE" x="267" y = "-184" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0006434"/>
<node id="C0151686" name="Growth retardation" semtype="patf" visible="true" color="#EEC8DE" x="324" y = "-9" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0151686"/>
<node id="C0025598" name="Metformin" semtype="orch" visible="true" color="#FFFFC6" x="200" y = "-56" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0025598"/>
<node id="C0070099" name="parathyroid hormone-related protein" semtype="aapp" visible="true" color="#FFFFC6" x="86" y = "-95" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0070099" entrezgene_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=5744"/>
<node id="C0035126" name="Reperfusion Injury" semtype="inpo" visible="true" color="#EEC8DE" x="46" y = "78" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0035126"/>
<node id="C0009319" name="Colitis" semtype="dsyn" visible="true" color="#EEC8DE" x="248" y = "136" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0009319"/>
<node id="C0006560" name="C-reactive protein" semtype="aapp" visible="true" color="#FFFFC6" x="431" y = "-70" umlsks_url="http://mor.nlm.nih.gov/perl/semnav.pl?DB_CODE=UMLS_2006AA&amp;HREL=ALL&amp;REM_TRANS=1&amp;CUI=C0006560" entrezgene_url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=1401"/>
<edge source="C0006560" target="C0021655" label="AUGMENTS" color="#40E0D0" ><sentence id = "16472048.ab.n" text = "Also, hsCRP levels increase with the stage of beta-cell dysfunction and insulin resistance."/></edge>
<edge source="C0166415" target="146" label="STIMULATES" color="#A52A2A" ><sentence id = "15754086.ab.n" text = "METHODS: mRNA expression levels for peroxisome proliferator activated receptor (PPAR) alpha, gamma and delta, PPARgamma co-factor 1 alpha and beta (PGC-1 alpha and beta), 9-cis retinoc-acid-activated receptor alpha, beta and gamma (RXR alpha, beta, gamma), 5'-AMP activated protein kinase (AMPK) alpha1 and alpha2, adiponectin receptor 1 and 2 (AR 1 and AR 2) were measured in heart tissue of neonatal 0-day, 7-day and 21- day old rats."/></edge>
<edge source="C1336636" target="C0122111" label="COEXISTS_WITH" color="#2F4F4F" ><sentence id = "18846339.ab.n" text = "The effect of rosiglitazone as the ligand of peroxisome proliferator-activated receptor gamma (PPARgamma) inhibiting the TLR4 expression in ischemic lobes in partial hepatic ischemia/reperfusion injury (IRI) in BABL/C mice and the action of rosiglitazone inhibiting the TLR4 receptor-mediated inherent immune response were investigated."/></edge>
<edge source="C0070099" target="C0016030" label="DISRUPTS" color="#FFFF00" ><sentence id = "17724498.ab.n" text = "Under the influence of conditions that predispose to CLD, normal PTHrP signaling is disrupted and interstitial fibroblasts transdifferentiate to myofibroblasts, the hallmark cell of CLD."/></edge>
<edge source="C0166417" target="C0021760" label="STIMULATES" color="#A52A2A" ><sentence id = "21455100.ab.n" text = "The antagonist of PPAR-gamma increased IL-6 in serum and decreased IL-10 in intestinal homogenates."/></edge>
<edge source="C0070099" target="C0038889" label="STIMULATES" color="#A52A2A" ><sentence id = "17724498.ab.n" text = "Stretch regulated parathyroid hormone-related protein (PTHrP) signaling between the alveolar type II (ATII) cell and the mesoderm coordinately upregulates the key genes for the homeostatic fibroblast phenotype, which in turn stimulates surfactant synthesis by ATII cells."/></edge>
<edge source="C0070099" target="C0225700" label="AUGMENTS" color="#40E0D0" ><sentence id = "17724498.ab.n" text = "Stretch regulated parathyroid hormone-related protein (PTHrP) signaling between the alveolar type II (ATII) cell and the mesoderm coordinately upregulates the key genes for the homeostatic fibroblast phenotype, which in turn stimulates surfactant synthesis by ATII cells."/></edge>
<edge source="C0303814" target="C0021760" label="STIMULATES" color="#A52A2A" ><sentence id = "21455100.ab.n" text = "Bisphenol A diglycidyl ether administrated to healthy animals increases serum IL-6 levels.&amp;amp;gt;br /&amp;amp;lt; Conclusions: Rosiglitazone inhibits experimental inflammation; administration of its selective antagonist abolishes this protective influence."/></edge>
<edge source="C0796494" target="C1336636" label="LOCATION_OF" color="#008000" ><sentence id = "18846339.ab.n" text = "As compared with vehicle group, the expression of TLR4 mRNA in ischemic lobes in rosiglitazone group was significantly decreased at 4 h after reperfusion."/><sentence id = "18846339.ab.n" text = "The most intensive expression of TLR4 mRNA was present at 4 h after reperfusion in ischemic lobes in vehicle group."/><sentence id = "18846339.ab.n" text = "After restoration of blood supply, the expression of TLR4 mRNA in ischemic lobes was detected in 0, 2, 4 and 6 h after reperfusion following 1 h ischemia in rosiglitazone group and vehicle group."/><sentence id = "18846339.ab.n" text = "The effect of rosiglitazone as the ligand of peroxisome proliferator-activated receptor gamma (PPARgamma) inhibiting the TLR4 expression in ischemic lobes in partial hepatic ischemia/reperfusion injury (IRI) in BABL/C mice and the action of rosiglitazone inhibiting the TLR4 receptor-mediated inherent immune response were investigated."/></edge>
<edge source="C0009319" target="C0034721" label="PROCESS_OF" color="#FA8072" ><sentence id = "21455100.ab.n" text = "Activated and inactivated PPARs-gamma modulate experimentally induced colitis in rats."/><sentence id = "21455100.ab.n" text = "Background: This study sought to define the mechanism by which PPAR-gamma ligands affect the course of experimentally induced colitis in rats.&amp;amp;gt;br /&amp;amp;lt; Material/Methods: Inflammation was induced in Wistar rats by a single rectal administration of 2,4,6,-trinitrobenzene sulfonic acid (TNBS)."/></edge>
<edge source="C0043552" target="C0166417" label="INHIBITS" color="#800080" ><sentence id = "19955116.ab.n" text = "Thiazolinediones are known to activate peroxisome proliferator-activated receptor gamma (PPAR-gamma) that decreases inflammation in humans and decreases shock induced by zymosan in mice."/></edge>
<edge source="C0220894" target="C0166417" label="INTERACTS_WITH" color="#FF00FF" ><sentence id = "18821250.ab.n" text = "We proceeded to dock TOTM, DEHP and its metabolites in order to identify compounds that are likely to interact with PPAR(alpha) and PPAR(gamma) binding sites."/></edge>
<edge source="C0021655" target="C0030305" label="COEXISTS_WITH" color="#2F4F4F" ><sentence id = "12766116.ab.n" text = "FPLD1 subjects also had components of the metabolic syndrome, including hypertension, insulin resistance, and severe hypertriglyceridemia resulting in pancreatitis."/></edge>
<edge source="C0289313" target="C0021760" label="INHIBITS" color="#800080" ><sentence id = "21455100.ab.n" text = "Rosiglitazone inhibits expression of proinflammatory IL-6 and does not affect IL-10."/></edge>
<edge source="C0166417" target="C0028754" label="ASSOCIATED_WITH" color="#D19275" ><sentence id = "19966034.ab.n" text = "The peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgamma coactivator-1alpha (PGC-1alpha) system plays an important role in the regulation of efficient energy utilization and oxidative phosphorylation, both of which are decreased in obesity and insulin resistance."/></edge>
<edge source="C0070099" target="C0166417" label="STIMULATES" color="#A52A2A" ><sentence id = "17724498.ab.n" text = "We have exploited the understanding of these molecular processes to demonstrate the proof-of-principle that by stabilizing the alveolar PTHrP signaling pathway using exogenously administered agonists of peroxisome proliferator-activated receptor-gamma a key target of PTHrP signaling, we can prevent and/or rescue the molecular injuries caused by insults that lead to CLD."/></edge>
<edge source="C0166417" target="146" label="STIMULATES" color="#A52A2A" ><sentence id = "15754086.ab.n" text = "METHODS: mRNA expression levels for peroxisome proliferator activated receptor (PPAR) alpha, gamma and delta, PPARgamma co-factor 1 alpha and beta (PGC-1 alpha and beta), 9-cis retinoc-acid-activated receptor alpha, beta and gamma (RXR alpha, beta, gamma), 5'-AMP activated protein kinase (AMPK) alpha1 and alpha2, adiponectin receptor 1 and 2 (AR 1 and AR 2) were measured in heart tissue of neonatal 0-day, 7-day and 21- day old rats."/></edge>
<edge source="C0021655" target="C0006434" label="COEXISTS_WITH" color="#2F4F4F" ><sentence id = "18695610.ab.n" text = "The profound hypermetabolic response to burn injury is associated with insulin resistance and hyperglycemia, significantly contributing to the incidence of morbidity and mortality in this patient population."/></edge>
<edge source="C1336636" target="C0035126" label="ASSOCIATED_WITH" color="#D19275" ><sentence id = "18846339.ab.n" text = "The effect of rosiglitazone as the ligand of peroxisome proliferator-activated receptor gamma (PPARgamma) inhibiting the TLR4 expression in ischemic lobes in partial hepatic ischemia/reperfusion injury (IRI) in BABL/C mice and the action of rosiglitazone inhibiting the TLR4 receptor-mediated inherent immune response were investigated."/></edge>
<edge source="C0028754" target="C0680323" label="PROCESS_OF" color="#FA8072" ><sentence id = "19966034.ab.n" text = "OBJECTIVE: Obesity and type 2 diabetes (T2D) are reaching epidemic proportions in Western societies, and they contribute to substantial morbidity and mortality."/></edge>
<edge source="C0166417" target="C0009319" label="AFFECTS" color="#32CD32" ><sentence id = "21455100.ab.n" text = "Activated and inactivated PPARs-gamma modulate experimentally induced colitis in rats."/></edge>
<edge source="C0025598" target="C0543567" label="TREATS" color="#0000FF" ><sentence id = "21625101.ab.n" text = "Insulin sensitizers such as metformin and PPAR-gamma agonists are either contraindicated or sparingly used due to their potential side effects, even in CHD patients with overt diabetes mellitus."/></edge>
<edge source="C0220894" target="C0166415" label="INTERACTS_WITH" color="#FF00FF" ><sentence id = "18821250.ab.n" text = "We proceeded to dock TOTM, DEHP and its metabolites in order to identify compounds that are likely to interact with PPAR(alpha) and PPAR(gamma) binding sites."/></edge>
<edge source="C0166417" target="C1512753" label="AFFECTS" color="#32CD32" ><sentence id = "19926821.ab.n" text = "Recent experimental studies have shown that the nuclear peroxisome proliferator activated receptor-gamma (PPARgamma) modulates the inflammatory process."/></edge>
<edge source="C0025598" target="C0166417" label="STIMULATES" color="#A52A2A" ><sentence id = "21157309.ab.n" text = "Investigation of alternative strategies, including the use of metformin, glucagon-like-peptide-1 and the PPAR-gamma agonists are under current investigation."/></edge>
<edge source="C0166417" target="C0206588" label="ISA" color="#00FFFF" ><sentence id = "17101152.ab.n" text = "Although the protein expression of a cytochrome (CYP) P-450 isoform CYP1A2 is reduced in the late stage of sepsis, the effect of hemorrhage on CYP isoforms and the anti-inflammatory nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) has not been investigated."/></edge>
<edge source="C0289313" target="C1336636" label="INHIBITS" color="#800080" ><sentence id = "18846339.ab.n" text = "Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice."/></edge>
<edge source="C0166417" target="C1336636" label="INHIBITS" color="#800080" ><sentence id = "18846339.ab.n" text = "The effect of rosiglitazone as the ligand of peroxisome proliferator-activated receptor gamma (PPARgamma) inhibiting the TLR4 expression in ischemic lobes in partial hepatic ischemia/reperfusion injury (IRI) in BABL/C mice and the action of rosiglitazone inhibiting the TLR4 receptor-mediated inherent immune response were investigated."/></edge>
<edge source="C0166417" target="C0151686" label="CAUSES" color="#FF0000" ><sentence id = "12495476.ab.n" text = "Specific ligands for peroxisome proliferator activated receptor gamma (PPAR-gamma) induce growth suppression in some tumor cells."/></edge>
<edge source="C0166417" target="C0021655" label="ASSOCIATED_WITH" color="#D19275" ><sentence id = "19966034.ab.n" text = "The peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgamma coactivator-1alpha (PGC-1alpha) system plays an important role in the regulation of efficient energy utilization and oxidative phosphorylation, both of which are decreased in obesity and insulin resistance."/></edge>

<seed value="PPAR gamma"/>
</graph>